Copyright
©The Author(s) 2024.
World J Gastroenterol. Jul 14, 2024; 30(26): 3221-3228
Published online Jul 14, 2024. doi: 10.3748/wjg.v30.i26.3221
Published online Jul 14, 2024. doi: 10.3748/wjg.v30.i26.3221
Table 1 Association of type of gastrointestinal procedure done with gender, presence of digestive symptoms prior to endoscopy, history of cannabis use, history of opioids or methadone use, and presence of residual food
Parameter | Type of diet one day prior to the procedure | P value | ||
Regular diet | Clear liquid/low residue diet | |||
Gender | Female | 112 | 81 | 0.713 |
Male | 68 | 45 | ||
Nausea, vomiting, dyspepsia, bloating (digestive symptoms) prior to endoscopy | No | 152 | 123 | < 0.001 |
Yes | 28 | 3 | ||
History of cannabis use | No | 165 | 108 | 0.099 |
Yes | 15 | 18 | ||
History of opioids or methadone use | No | 172 | 118 | 0.461 |
Yes | 8 | 8 | ||
Presence of residual food | No | 162 | 124 | 0.03 |
Yes | 18 | 2 |
- Citation: Ghazanfar H, Javed N, Qasim A, Sosa F, Altaf F, Khan S, Mahasamudram J, Jyala A, Kandhi SD, Shin D, Mantri N, Sun H, Hanumanthu S, Patel H, Makker J, Balar B, Dev A, Chilimuri S. Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study. World J Gastroenterol 2024; 30(26): 3221-3228
- URL: https://www.wjgnet.com/1007-9327/full/v30/i26/3221.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i26.3221